ALMGDA
UTHR icon

AG2R La Mondiale Gestion d'Actifs’s United Therapeutics UTHR Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
+2,393
New +$1.35M 0.05% 323

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

AG2R La Mondiale Gestion d'Actifs's UTHR Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,393 shares worth $1.3M. The stake represents 0.05% of the portfolio and ranks #323 among its holdings.

884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 2,393 shares of United Therapeutics worth $1.3M as of Q2 2026.
  • United Therapeutics was a new AG2R La Mondiale Gestion d'Actifs position in Q2 2026.
  • United Therapeutics made up 0.05% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #323 holding.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.